MedTrace Logo

Invasive Pulmonary Aspergillosis Complicating Influenza Infection

NCT03391492 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 298

Last updated 2021-07-30

No results posted yet for this study

Summary

Study the incidence and outcome of invasive pulmonary aspergillosis (IPA) in ICU patients with severe influenza and in influenza-negative control patients with severe community-acquired pneumonia

Conditions

  • Influenza With Pneumonia
  • Aspergillosis Invasive

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Joost Wauters, Phd · UZ Leuven

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-20
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03391492 on ClinicalTrials.gov